New era of uveitis: Embracing the modern technology (ARVO Education Session)
Register with ARVO's All-Access Saturday pass
Saturday, May 3
8am – 5pm MT
Calvin L. Rampton Salt Palace Convention Center
Organizers
Vishali Gupta, MD, Chair, Rupesh Vijay Agrawal, MD, FRCS, MMed, Esen K Akpek, MD, David S Chu, MD, Phoebe Lin, MD, PhD, Careen Y Lowder, MD, PhD, Quan Dong Nguyen, MD MSc, FARVO and Carlos E Pavesio, FRCOphth, MD.
Participating Societies
The following societies participated in the development of this course.
- American Uveitis Society
- Foster Ocular Immunology Society
- International Ocular Inflammation Society
- International Uveitis Study Group
- Sociedad Panamericana de Enfermedades Inflamatorias Oculares
Target Audience
These sessions are intended for basic and clinical researchers and healthcare professionals with knowledge of the diagnosis, treatment and management of uveitis including ocular imaging techniques.
From Conventional labs to Omics: What has changed in the diagnosis of uveitis?
8am - 10:05am
This session will highlight the significant advancements in diagnostics, which have evolved from a few basic laboratory tests to cutting-edge 'omics' technologies. Participants will learn from expert presentations and case studies and two debates: Bayesian Breakthrough: Can it Guide patient treatment in Uveitis? and Personalized Medicine: Innovation or Passing Trend?
Decoding multimodal imaging and artificial intelligence for daily uveitis practice
10:30am - 12:05pm
This session will highlight the advances in the field of imaging as well as integration of Artificial intelligence in our practice and patient management. "Combining the old with new is an art that needs to be learnt and mastered." Participants will learn from expert presentations and case studies. The session will end with a debate, AI in Imaging Interpretation; Do I trust it?
Cutting edge treatments for uveitis
1:05pm - 3:05pm
This session will highlight the advances in the field of treatment of uveitis. The experts shall cover a wide array of spectrum beginning with conventional treatment and elaborating on round the corner newer therapies including both local and systemic therapies. Participants will learn from expert presentations and case studies and two debates: Local therapy : Saves patients from Systemic side effects and Systemic therapy with Biologics : First Line or Last Resort?
Clinical trials in uveitis: What everyone needs to know
3:30pm - 5pm
This session will explore clinical trials for uveitis classification, standardizing imaging nomenclature and incorporating AI tools in uveitis clinical trials. The session will close with a discussion on defining endpoints.
